Investments
1Portfolio Exits
1Partners & Customers
10
Want to inform investors similar to Nemours Children's Health about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Nemours Children's Health News
Nov 30, 2022
News provided by Share this article Additional Clinical and Regional Roles Created to Support Growth JACKSONVILLE, Fla., Nov. 30, 2022 /PRNewswire/ -- Nemours Children's Health has promoted Mark Mumford, Chief Executive of Delaware Valley Operations, to Enterprise Chief Operating Officer (COO) for the multistate, multisite children's health system. Mumford is based in Wilmington, Del., and reports to Nemours Children's President and CEO R. Lawrence Moss, MD, FACS, FAAP. In addition, five new clinical and regional leadership roles were created to support Nemours Children's continued innovation and aspirational strategic plan. "Mark is the quintessential servant leader, and his consummate expertise in health care operations is critical to achieving our vision of creating the healthiest generations of children," said Nemours Children's President and CEO R. Lawrence Moss, MD. "As we evolve our children's health system for continued operational excellence, innovation, and the expansion of value-based care, Mark is the right leader at the right time to help Nemours Children's achieve our strategic goals." "I joined Nemours two years ago because it was the only health care system in the country that had a bold plan and vision to not only help children recover from illness but to prevent them from getting sick in the first place," said Mumford. "I knew that this was where I wanted to be. All of us at Nemours are committed to going well beyond medicine to help even more children access the best care, outcomes, and comprehensive approach to their well-being." Nemours Children's Health also announced two new enterprise clinical leadership roles and segmented its growing Florida operation into two regions. Each of Nemours three regions will have a local president with the following promotions effective today: Mary M. Lee, MD, Enterprise Chief Physician Executive and Chief Scientific Officer Jane Mericle, DNP, Enterprise Chief Nursing Executive and Patient Operations Officer Michael Erhard, MD, President, Nemours Children's Health, North Florida Martha McGill, MBA, President, Nemours Children's Health, Central Florida A national search for the Delaware Valley regional president is underway, and Mark Mumford will serve in a dual role in the interim. In their new roles, Drs. Lee and Mericle, who are also based in Wilmington, will provide leadership for clinical operations across the four states where Nemours operates two hospitals and provides primary, specialty, and urgent care. Drs. Lee and Mericle report directly to Mumford with a dotted line to Nemours Children's President and CEO, R. Lawrence Moss, MD. For more information, visit https://nemours.mediaroom.com/MarkMumfordNamedCOO . About Nemours Children's Health Nemours Children's Health is one of the nation's largest multistate pediatric health systems, which includes two free-standing children's hospitals and a network of more than 70 primary, specialty, and urgent care practices. Nemours Children's seeks to transform the health of children by adopting a holistic health model that utilizes innovative, safe, and high-quality care while also caring for the health of the whole child beyond medicine. Nemours Children's also powers the world's most-visited website for information on the health of children and teens, Nemours KidsHealth.org . The Nemours Foundation, established through the legacy and philanthropy of Alfred I. duPont, provides pediatric clinical care, research, education, advocacy, and prevention programs to the children, families, and communities it serves. For more information, visit Nemours.org . SOURCE Nemours Children's Health
Nemours Children's Health Investments
1 Investments
Nemours Children's Health has made 1 investments. Their latest investment was in La Jolla Pharmaceutical Company as part of their Unattributed VC - IV on January 1, 2002.

Nemours Children's Health Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
1/18/2002 | Unattributed VC - IV | La Jolla Pharmaceutical Company | $51.59M | Yes | Alfred I. duPont Testamentary Trust, AWM Investment Company, Bain Capital Public Equity, Deerfield Management, Deka Investment, DekaTeam-BioTech, East Bay Municipal Utility District, EGS Healthcare Capital Partners, ING, J.P. Morgan Chase & Co., Memorial Hospital Of South Bend, Nemours Children's Health, RS Investments, Safeco, SF Capital Group, UBS, Undisclosed Investors, Utah Retirement Systems, and Zeke |
Date | 1/18/2002 |
---|---|
Round | Unattributed VC - IV |
Company | La Jolla Pharmaceutical Company |
Amount | $51.59M |
New? | Yes |
Co-Investors | Alfred I. duPont Testamentary Trust, AWM Investment Company, Bain Capital Public Equity, Deerfield Management, Deka Investment, DekaTeam-BioTech, East Bay Municipal Utility District, EGS Healthcare Capital Partners, ING, J.P. Morgan Chase & Co., Memorial Hospital Of South Bend, Nemours Children's Health, RS Investments, Safeco, SF Capital Group, UBS, Undisclosed Investors, Utah Retirement Systems, and Zeke |
Sources |
Nemours Children's Health Portfolio Exits
1 Portfolio Exit
Nemours Children's Health has 1 portfolio exit. Their latest portfolio exit was La Jolla Pharmaceutical Company on February 06, 2006.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
2/6/2006 | IPO | Public |
Date | 2/6/2006 |
---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | Public |
Sources |
Nemours Children's Health Acquisitions
1 Acquisition
Nemours Children's Health acquired 1 company. Their latest acquisition was Main Line Health on January 23, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
1/23/2023 | Acquired | 1 |
Date | 1/23/2023 |
---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources | 1 |
Nemours Children's Health Partners & Customers
10 Partners and customers
Nemours Children's Health has 10 strategic partners and customers. Nemours Children's Health recently partnered with Foundation for the National Institutes of Health on May 5, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
5/16/2023 | Partner | United States | Nemours Children’s Health to host first gene therapy clinical trial for Morquio A syndrome Nemours Children 's Health will work collaboratively with the Foundation for the National Institutes of Health ® BGTC , A public-private partnership between the National Institutes of Health , U.S. Food and Drug Administration , biopharmaceutical and life science companies , and non-profit and other organizations , to help speed the development and delivery of customized or ` bespoke ' gene therapies . | 3 | |
3/16/2023 | Vendor | United States | STOUGHTON , Mass. & WILMINGTON , Del. -- -- Shields Health Solutions , the premier specialty pharmacy accelerator in the country , announced today that it has partnered with Nemours Children 's Health , Delaware , to collaborate in developing a specialty pharmacy program that will provide patients with complex , chronic conditions access to specialized pharmacy services designed to lower costs , expand treatment options , enhance medication management , and improve overall health . | 1 | |
10/5/2022 | Partner | United States | `` Florida Blue values health care organizations like Nemours that share our commitment to addressing affordability by prioritizing our patients ' health and well-being , '' said Phil Lee , Florida Blue 's Vice President , Strategic Provider Partnerships . | 1 | |
9/22/2021 | Partner | ||||
9/28/2020 | Partner |
Date | 5/16/2023 | 3/16/2023 | 10/5/2022 | 9/22/2021 | 9/28/2020 |
---|---|---|---|---|---|
Type | Partner | Vendor | Partner | Partner | Partner |
Business Partner | |||||
Country | United States | United States | United States | ||
News Snippet | Nemours Children’s Health to host first gene therapy clinical trial for Morquio A syndrome Nemours Children 's Health will work collaboratively with the Foundation for the National Institutes of Health ® BGTC , A public-private partnership between the National Institutes of Health , U.S. Food and Drug Administration , biopharmaceutical and life science companies , and non-profit and other organizations , to help speed the development and delivery of customized or ` bespoke ' gene therapies . | STOUGHTON , Mass. & WILMINGTON , Del. -- -- Shields Health Solutions , the premier specialty pharmacy accelerator in the country , announced today that it has partnered with Nemours Children 's Health , Delaware , to collaborate in developing a specialty pharmacy program that will provide patients with complex , chronic conditions access to specialized pharmacy services designed to lower costs , expand treatment options , enhance medication management , and improve overall health . | `` Florida Blue values health care organizations like Nemours that share our commitment to addressing affordability by prioritizing our patients ' health and well-being , '' said Phil Lee , Florida Blue 's Vice President , Strategic Provider Partnerships . | ||
Sources | 3 | 1 | 1 |
Nemours Children's Health Team
4 Team Members
Nemours Children's Health has 4 team members, including current Chief Information Officer, Senior Vice President, Bernie Rice.
Name | Work History | Title | Status |
---|---|---|---|
Bernie Rice | Chief Information Officer, Senior Vice President | Current | |
Name | Bernie Rice | |||
---|---|---|---|---|
Work History | ||||
Title | Chief Information Officer, Senior Vice President | |||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.